Regions

The behavioral health company's Engage platform will be available to existing commercial fully insured, self-funded members on an opt-in basis and via Sentara's Marketplace membership.

The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.

We're facing an average of two data breaches a day across the country, says Greg Garcia, executive director of the Health Sector Coordinating Council Cybersecurity Working Group. Still, we have the tools to respond to and mitigate the damage.

The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.

The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.

The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.  

The funding will support clinical trials for the company's NeuroHawk brain-scanning device.  

Attorney Everett Wilson, managing partner at Polsinelli's Miami office, discusses overall changes in Medicare and Medicare Advantage - and how the recent benefits changes affect consumers, payers and plans.

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.